Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study

Pixium Vision announces positive long-term data from patients implanted with PRIMA, a state-of-the-art implantable chip. The data were presented at The Eye and The Chip – Virtual Event, held October 3-5, 2021.

• PRIMA implant is well tolerated and safe in patients 36 months after implantation
• Implant is highly stable with no lifetime deteriorations observed
• PRIMA can potentially provide meaningful visual acuity improvement